ArticleProceedings of the National Academy of Sciences of the United States of America2020
Kpi, a chaperone-usher pili system associated with the worldwide-disseminated high-risk clone
Abstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Therapeutic strategies against biofilm-associated multidrug-resistantFrontiers in microbiology · 2026Review
- Genomic and virulence characterization of OXA-48-producingFrontiers in microbiology · 2026Article
- A novelVirulence · 2025Article
- Probiotic potential and antimicrobial efficacy of a dairy isolate, Enterococcus faecium MBBL3.Applied microbiology and biotechnology · 2025Article
- Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.Nature reviews. Microbiology · 2025Review
- Regulatory effects on virulence and phage susceptibility revealed byFrontiers in cellular and infection microbiology · 2025Article
- WGS-based screening of the co-chaperone protein DjlA-induced curved DNA binding protein A (CbpA) from a new multidrug-resistant zoonotic mastitis-causing Klebsiella pneumoniae strain: a novel molecular target of selective flavonoids.Molecular diversity · 2024Article
- Relevance of the Adjuvant Effect between Cellular Homeostasis and Resistance to Antibiotics in Gram-Negative Bacteria with Pathogenic Capacity: A Study ofAntibiotics (Basel, Switzerland) · 2024Review
- Carbapenem-resistantJAC-antimicrobial resistance · 2024Article
- DecodingFrontiers in microbiology · 2024Article
- Article
- Widespread Detection of Yersiniabactin Gene Cluster and Its Encoding Integrative Conjugative Elements (ICEMicrobiology spectrum · 2023Article
- From Farm to Fork: Persistence of Clinically Relevant Multidrug-Resistant and Copper-Tolerant Klebsiella pneumoniae Long after Colistin Withdrawal in Poultry Production.Microbiology spectrum · 2023Article
- Article
- Phylogenomics of Globally Spread Clonal Groups 14 and 15 of Klebsiella pneumoniae.Microbiology spectrum · 2023Article
- Multiplexed Target Enrichment Enables Efficient and In-Depth Analysis of Antimicrobial Resistome in Metagenomes.Microbiology spectrum · 2022Article
- Pandemic Clones of CTX-M-15 ProducingMicroorganisms · 2022Article
- Article
- Prevalence of Efflux Pump and Porin-Related Antimicrobial Resistance in ClinicalArchives of Razi Institute · 2022Article
- Three Novel Sequence Types Carbapenem-Resistant Klebsiella pneumoniae Strains ST5365, ST5587, ST5647 Isolated from Two Tertiary Teaching General Hospitals in Shanxi Province, in North China: Molecular Characteristics, Resistance and Virulence Factors.Infection and drug resistance · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Eva GatoDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.ORCID 0000-0002-1662-514X
Juan Carlos Vázquez-UchaDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.ORCID 0000-0003-4949-0779
Soraya Rumbo-FealDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.ORCID 0000-0002-1796-1815
Laura Álvarez-FragaDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.
Juan A VallejoDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.ORCID 0000-0002-7581-8654
Marta Martínez-GuitiánDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.ORCID 0000-0002-3457-0613
Alejandro BeceiroDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.
Jose Ramos VivasLaboratorio de Microbiología, Instituto de Investigación Sanitaria Valdecilla, 39011 Santander, Spain.ORCID 0000-0001-8795-519X
Pedro J Sola CampoyLaboratorio de Referencia en Resistencia a Antibióticos, Centro Nacional de Microbiología Instituto de Salud Carlos III, 28222 Madrid, Spain.ORCID 0000-0002-5881-7377
María Pérez-VázquezLaboratorio de Referencia en Resistencia a Antibióticos, Centro Nacional de Microbiología Instituto de Salud Carlos III, 28222 Madrid, Spain.ORCID 0000-0003-0745-8914
Jesus Oteo IglesiasLaboratorio de Referencia en Resistencia a Antibióticos, Centro Nacional de Microbiología Instituto de Salud Carlos III, 28222 Madrid, Spain.ORCID 0000-0003-3327-8263
Bruno Kotska Rodiño-JaneiroDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.ORCID 0000-0002-0633-6774
Antonio RomeroCentro de Investigaciones Biológicas, 28040 Madrid, Spain.ORCID 0000-0002-6990-6973
Margarita PozaDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain.
Germán BouDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain; german.bou.arevalo@sergas.es astrid.perez.gomez@sergas.es.ORCID 0000-0001-8837-0062
Astrid PérezDepartamento de Microbiología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, Universidad de A Coruña 15006 A Coruña, Spain; german.bou.arevalo@sergas.es astrid.perez.gomez@sergas.es.ORCID 0000-0003-1809-3332
Funding
No grant is acknowledged in the PubMed record.
Abstract
Control of infections caused by carbapenem-resistant
Indexed as
A549 CellsAnimalsAnti-Bacterial AgentsBacterial AdhesionBiofilmsCarbapenemsCell LineDisease Models, AnimalDrug Resistance, Multiple, BacterialEpithelial CellsEuropeFemaleFimbriae, BacterialGene DeletionGenes, BacterialHumansAnti-Bacterial AgentsCarbapenemsMolecular Chaperoneschaperone-usher pili systemGI tract colonizationKlebsiella pneumoniaepathogenesisST-15 high-risk clone
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.